ABIONYX Pharma SA (EPA:ABNX)
3.800
-0.030 (-0.78%)
At close: Jan 30, 2026
ABIONYX Pharma Employees
ABIONYX Pharma had 51 employees as of December 31, 2024. The number of employees decreased by 10 or -16.39% compared to the previous year.
Employees
51
Change (1Y)
-10
Growth (1Y)
-16.39%
Revenue / Employee
€84,824
Profits / Employee
€90,176
Market Cap
134.06M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 51 | -10 | -16.39% |
| Dec 31, 2023 | 61 | -2 | -3.17% |
| Dec 31, 2022 | 63 | 1 | 1.61% |
| Dec 31, 2021 | 62 | 59 | 1,671.43% |
| Dec 31, 2020 | 4 | 1 | 40.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 222 |
| Genfit | 188 |
| Innate Pharma | 181 |
| Transgene | 147 |
| Adocia | 77 |
| Sensorion | 68 |
| MaaT Pharma | 65 |
| OSE Immunotherapeutics | 64 |